Aion Therapeutic Inc. (AION.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 163.11 Thousand CAD | N/A |
| 2022 | 975.69 Thousand CAD | -65.39% |
| 2021 | 2.81 Million CAD | 1.4% |
| 2020 | 2.78 Million CAD | 182.91% |
| 2019 | 982.64 Thousand CAD | -42.22% |
| 2018 | 1.7 Million CAD | 719.94% |
| 2017 | 207.42 Thousand CAD | 65.17% |
| 2016 | 125.58 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 327.98 Thousand CAD | 19.53% |
| 2023 Q1 | 165.3 Thousand CAD | -2.54% |
| 2023 Q2 | 274.39 Thousand CAD | 66.0% |
| 2022 Q1 | 331.75 Thousand CAD | -76.5% |
| 2022 Q3 | 246.95 Thousand CAD | 8.61% |
| 2022 Q2 | 227.37 Thousand CAD | -31.46% |
| 2022 Q4 | 169.6 Thousand CAD | -31.32% |
| 2022 FY | 975.69 Thousand CAD | -65.39% |
| 2021 FY | 2.81 Million CAD | 1.4% |
| 2021 Q4 | 1.41 Million CAD | 302.0% |
| 2021 Q3 | 351.23 Thousand CAD | -40.91% |
| 2021 Q2 | 594.42 Thousand CAD | 28.86% |
| 2021 Q1 | 461.3 Thousand CAD | -57.69% |
| 2020 Q1 | 463.7 Thousand CAD | 106.3% |
| 2020 Q3 | 528.61 Thousand CAD | -24.2% |
| 2020 Q2 | 697.35 Thousand CAD | 50.39% |
| 2020 FY | 2.78 Million CAD | 182.91% |
| 2020 Q4 | 1.09 Million CAD | 106.27% |
| 2019 Q1 | 356.19 Thousand CAD | -25.1% |
| 2019 Q2 | 201.35 Thousand CAD | -43.47% |
| 2019 Q3 | 200.31 Thousand CAD | -0.52% |
| 2019 Q4 | 224.77 Thousand CAD | 12.21% |
| 2019 FY | 982.64 Thousand CAD | -42.22% |
| 2018 Q2 | 673.39 Thousand CAD | 226.34% |
| 2018 FY | 1.7 Million CAD | 719.94% |
| 2018 Q4 | 475.55 Thousand CAD | 37.66% |
| 2018 Q3 | 345.46 Thousand CAD | -48.7% |
| 2018 Q1 | 206.34 Thousand CAD | -88.33% |
| 2017 Q4 | 1.76 Million CAD | 790.67% |
| 2017 FY | 207.42 Thousand CAD | 65.17% |
| 2017 Q2 | 673.17 Thousand CAD | 0.0% |
| 2017 Q3 | 198.59 Thousand CAD | -70.5% |
| 2016 FY | 125.58 Thousand CAD | 0.0% |
| 2015 Q3 | 8900.00 CAD | 0.0% |
| 2015 Q1 | 3048.00 CAD | 0.0% |
| 2014 Q3 | 11.32 Thousand CAD | 0.0% |
| 2014 Q1 | 9274.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ayurcann Holdings Corp. | 11.71 Million CAD | 98.608% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -93.668% |
| The BC Bud Corporation | 1.28 Million CAD | 87.286% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 97.58% |
| CordovaCann Corp. | 3.86 Million CAD | 95.776% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 96.192% |
| Captor Capital Corp. | 16.28 Million CAD | 98.998% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | 76.886% |
| 1CM Inc. | 7.3 Million CAD | 97.768% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | 70.434% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 96.607% |
| IM Cannabis Corp. | 22.63 Million CAD | 99.279% |
| Lobe Sciences Ltd. | 4.13 Million CAD | 96.053% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | 58.411% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -171.862% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | 90.774% |
| Ovation Science Inc. | 54.1 Thousand CAD | -201.51% |
| Pharmadrug Inc. | 1.33 Million CAD | 87.782% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | 87.505% |
| RAMM Pharma Corp. | 7.48 Million CAD | 97.819% |
| RIV Capital Inc. | 21.1 Million CAD | 99.227% |
| Revive Therapeutics Ltd. | 3.28 Million CAD | 95.036% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 99.568% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 99.337% |
| 1933 Industries Inc. | 5.12 Million CAD | 96.817% |
| Red Light Holland Corp. | 2.02 Million CAD | 91.927% |
| Top Strike Resources Corp. | 3.63 Million CAD | 95.509% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 152.888% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 98.257% |